Giant cell myocarditis or sarcoidosis? Time to develop clinically driven non-invasive decision algorithms in inflammatory myocardial diseases: integrating clinical features, biomarkers and multimodality imaging
1. Giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare inflammatory myocardial diseases associated with substantial morbidity and mortality [1]. While GCM primarily represents a fulm...
Authors
- Christian L. Polte (ORCID: https://orcid.org/0000-0001-7125-9747)
- Entela Bollano (ORCID: https://orcid.org/0000-0003-3341-2434)
- Emanuele Bobbio (ORCID: https://orcid.org/0000-0002-8287-2448)
- Carsten Tschöpe
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
- Sahlgrenska University Hospital (SE)
- Deutsches Herzzentrum der Charité (DE)
- Berlin-Brandenburger Centrum für Regenerative Therapien (DE)
- German Centre for Cardiovascular Research (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Expert Review of Cardiovascular Therapy
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1080/14779072.2026.2692679
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00